| Dr Charles Miller, MD | |
|
935 State Farm Rd, Boone, NC 28607-4948 | |
| (828) 264-5150 | |
| (828) 265-3611 |
| Full Name | Dr Charles Miller |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 38 Years |
| Location | 935 State Farm Rd, Boone, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528168549 | NPI | - | NPPES |
| 8958881 | Medicaid | NC | |
| 58881 | Other | NC | BLUE CROSS |
| 2158301B | Other | NC | PSC MEDICARE PROVIDER NUM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 31739 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Watauga Medical Center | Boone, NC | Hospital |
| North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
| Charles A Cannon Jr Memorial Hospital | Linville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Stone Center Pllc | 2961315718 | 61 |
| Appalachian Regional Medical Associates Inc | 5799877817 | 83 |
News Archive
San Diego State University researcher Roger Sabbadini has brought scientists one step closer to finding a cure for cancer with the creation of an antibody that hinders the growth of tumors by preventing blood vessel formation.
Two new studies from the Tobacco Control Research Group at the University of Bath, published in the BMJ journal, Tobacco Control, expose evidence that big tobacco companies are still facilitating tobacco smuggling, while attempting to control a global system designed to prevent it, and funding studies that routinely overestimate levels of tobacco smuggling.
iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc. pursuant to which iTeos will license to Pfizer rights to iTeos' pre-clinical compounds targeting Indoleamine 2,3-dioxygenase (IDO1) and Tryptophan 2,3-dioxygenase (TDO2). Pfizer will be responsible for the development and commercialization of IDO1 and TDO2 drug candidates.
While nearly 400,000 residents of long-term care facilities die as a result of healthcare-associated infections (HAIs), these facilities continue to lack the resources, including qualified personnel, necessary to implement adequate infection control programs, according to research presented at the 44th Annual Conference of the Association for Professionals in Infection Control and Epidemiology
› Verified 5 days ago
| Entity Name | Piedmont Stone Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700827409 PECOS PAC ID: 2961315718 Enrollment ID: O20031107000688 |
News Archive
San Diego State University researcher Roger Sabbadini has brought scientists one step closer to finding a cure for cancer with the creation of an antibody that hinders the growth of tumors by preventing blood vessel formation.
Two new studies from the Tobacco Control Research Group at the University of Bath, published in the BMJ journal, Tobacco Control, expose evidence that big tobacco companies are still facilitating tobacco smuggling, while attempting to control a global system designed to prevent it, and funding studies that routinely overestimate levels of tobacco smuggling.
iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc. pursuant to which iTeos will license to Pfizer rights to iTeos' pre-clinical compounds targeting Indoleamine 2,3-dioxygenase (IDO1) and Tryptophan 2,3-dioxygenase (TDO2). Pfizer will be responsible for the development and commercialization of IDO1 and TDO2 drug candidates.
While nearly 400,000 residents of long-term care facilities die as a result of healthcare-associated infections (HAIs), these facilities continue to lack the resources, including qualified personnel, necessary to implement adequate infection control programs, according to research presented at the 44th Annual Conference of the Association for Professionals in Infection Control and Epidemiology
› Verified 5 days ago
| Entity Name | Appalachian Regional Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669533923 PECOS PAC ID: 5799877817 Enrollment ID: O20070822000932 |
News Archive
San Diego State University researcher Roger Sabbadini has brought scientists one step closer to finding a cure for cancer with the creation of an antibody that hinders the growth of tumors by preventing blood vessel formation.
Two new studies from the Tobacco Control Research Group at the University of Bath, published in the BMJ journal, Tobacco Control, expose evidence that big tobacco companies are still facilitating tobacco smuggling, while attempting to control a global system designed to prevent it, and funding studies that routinely overestimate levels of tobacco smuggling.
iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc. pursuant to which iTeos will license to Pfizer rights to iTeos' pre-clinical compounds targeting Indoleamine 2,3-dioxygenase (IDO1) and Tryptophan 2,3-dioxygenase (TDO2). Pfizer will be responsible for the development and commercialization of IDO1 and TDO2 drug candidates.
While nearly 400,000 residents of long-term care facilities die as a result of healthcare-associated infections (HAIs), these facilities continue to lack the resources, including qualified personnel, necessary to implement adequate infection control programs, according to research presented at the 44th Annual Conference of the Association for Professionals in Infection Control and Epidemiology
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Miller, MD 935 State Farm Rd, Boone, NC 28607-4948 Ph: (828) 264-5150 | Dr Charles Miller, MD 935 State Farm Rd, Boone, NC 28607-4948 Ph: (828) 264-5150 |
News Archive
San Diego State University researcher Roger Sabbadini has brought scientists one step closer to finding a cure for cancer with the creation of an antibody that hinders the growth of tumors by preventing blood vessel formation.
Two new studies from the Tobacco Control Research Group at the University of Bath, published in the BMJ journal, Tobacco Control, expose evidence that big tobacco companies are still facilitating tobacco smuggling, while attempting to control a global system designed to prevent it, and funding studies that routinely overestimate levels of tobacco smuggling.
iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc. pursuant to which iTeos will license to Pfizer rights to iTeos' pre-clinical compounds targeting Indoleamine 2,3-dioxygenase (IDO1) and Tryptophan 2,3-dioxygenase (TDO2). Pfizer will be responsible for the development and commercialization of IDO1 and TDO2 drug candidates.
While nearly 400,000 residents of long-term care facilities die as a result of healthcare-associated infections (HAIs), these facilities continue to lack the resources, including qualified personnel, necessary to implement adequate infection control programs, according to research presented at the 44th Annual Conference of the Association for Professionals in Infection Control and Epidemiology
› Verified 5 days ago
Dr. James Lawrence Hamby, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 935 State Farm Rd, Boone, NC 28607 Phone: 828-264-5150 Fax: 828-265-3611 | |
Anthony Michael Schlake, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 935 State Farm Road, Boone, NC 28607 Phone: 859-323-5871 |